Abstract
The antidepressant rolipram interacts in vitro with a binding site in brain tissue labeled by3H-rolipram. A3H-rolipram binding assay was employed in vivo to compare the affinity of rolipram-related compounds and reference phosphodiesterase (PDE) inhibitors with their potency in behavioural measures for potential antidepressant property. In two species, mice and rats, the potency of a number of compounds to antagonise reserpine-induced hypothermia (mice) and to induce head twitches (rats) was determined, as well as their potency to displace3H-rolipram from forebrain binding sites in vivo. The treatment schedules for the two series of experiments were identical. Significant correlations between pharmacological effects and displacement of3H-rolipram binding in vivo were observed in both species. Since the reference PDE inhibitors closely fit into the binding-pharmacological activity relationship, the PDE inhibitory properties of the substances involved are discussed.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Askew BM (1963) A simple screening procedure for imipramine-like antidepressant agents. Life Sci 2:725–730
Bertolino A, Crippa D, DiDio S, Fichte K, Musmeci G, Porro V, Rapisarda V, Sastre-y-Hernandez M, Schratzer M (1988) Rolipram versus imipramine in inpatients with major, “minor” or atypical depressive disorder: a double-blind double-dummy study aimed at testing a novel therapeutic approach. Int Clin Psychopharmacol 3:245–253
Bobon D, Breulet M, Gerard-Vandenhove M-A, Guiot-Goffioul F, Plomteux G, Sastre-y-Hernandez M, Schratzer M, Troisfontaine B, von Frenkell R, Wachtel H (1988) Is phosphodiesterase inhibition a new mechanism of antidepressant action? Eur Arch Psychiatr Neurol Sci 238:2–6
Davis CW (1984) Assessment of selective inhibition of rat cerebral cortical calcium-independent and calcium-dependent phosphodiesterase in crude extracts using deoxycyclic AMP and potassium ions. Biochim Biophys Acta 797:354–362
Eckmann F, Fichte K, Meya U, Sastre-y-Hernandez M (1988) Rolipram in major depression: results of a double-blind comparative study with amitriptyline. Curr Ther Res 43:291–295
Glaser T, Traber J (1984) TVX 2706 — a new phosphodiesterase inhibitor with antiinflammatory action. Biochemical characterization. Agents Actions 15:341–348
Kaulen P, Schneider HH, Sarter M, Baumgarten HG (1989) Autoradiographic mapping of a selective cyclic adenosine monophosphate phosphodiesterase in rat brain with the antidepressant3H-rolipram. Brain Res 503:229–245
Kehr W, Debus G, Neumeister R (1985) Effects of rolipram, a novel antidepressant, on monoamine metabolism in rat brain. J Neural Transm 63:1–12
Minneman KP (1976) Cyclic nucleotide phosphodiesterase in rat neostriatum: multiple isoelectric forms with similar kinetic properties. J Neurochem 27:1181–1189
Nicholson CD, Jackman SA, Wilke R (1989) The ability of denbufylline to inhibit cyclic nucleotide phosphodiesterase and its affinity for adenosine receptors and the adenosine re-uptake site. Br J Pharmacol 97:889–897
Ross SB, Renyi AL (1967) Inhibition of the uptake of tritiated catecholamines by antidepressant and related agents. Eur J Pharmacol 2:181–186
Schneider HH (1984) Brain response to phosphodiesterase inhibitors in rats killed by microwave irradiation or decapitation. Biochem Pharmacol 33:1690–1693
Schneider HH, Schmiechen R, Brezinski M, Seidler J (1986) Stereospecific binding of the antidepressant rolipram to brain protein structures. Eur J Pharmacol 127:105–115
Schneider HH, Pahlke G, Schmiechen R (1988) Sensitivity of a cAMP PDE to rolipram in different organs. In: Heilmeyer LMG (ed) Signal transduction and protein phosphorylation, NATO ASI Series A, vol 135. Plenum Press, New York, pp 81–85
van Riezen H, Delver A (1971) The effect of a number of drugs with different pharmacological properties upon reserpine induced hypothermia in mice. Arzneimittelforschung 21:1562–1566
Wachtel H (1982) Characteristic behavioural alterations in rats induced by rolipram and other selective adenosine cyclic 3',5'-monophosphate phosphodiesterase inhibitors. Psychopharmacology 77:309–316
Wachtel H (1983) Potential antidepressant activity of rolipram and other selective cyclic adenosine 3',5'-monophosphate phosphodiesterase inhibitors. Neuropharmacology 22:267–272
Wachtel H, Schneider HH (1986) Rolipram, a novel antidepressant drug, reverses the hypothermia and hypokinesia of monoamine-depleted mice by an action beyond postsynaptic monoamine receptors. Neuropharmacology 25:1119–1126
Wachtel H (1989) Dysbalance of neuronal second messenger function in the etiology of affective disorders: a pathophysiological concept hypothesising defects beyond first messenger receptors. J Neural Transm 75:21–29
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schmiechen, R., Schneider, H.H. & Wachtel, H. Close correlation between behavioural response and binding in vivo for inhibitors of the rolipram-sensitive phosphodiesterase. Psychopharmacology 102, 17–20 (1990). https://doi.org/10.1007/BF02245738
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02245738